Web Results

FluGen Inc. Focused on Efficacy – Paul V. Radspinner

flugen.com/paul-v-radspinner/

Founder, President and Chief Executive Officer. Mr. Radspinner has over 15 years of experience in management roles overseeing international pharmaceutical ...

FluGen Inc. Focused on Efficacy

flugen.com/

REDEE FLU™ shows promise as a universal flu vaccine. At FluGen we're dedicated to improving public health by developing a vaccine that can prevent ...

Paul Radspinner | LinkedIn

www.linkedin.com/in/paul-radspinner-a851b610

View Paul Radspinner's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Paul Radspinner discover ...

FluGen Snags $9.4M for Phase I Trial of Universal Flu Vaccine ...

www.xconomy.com/wisconsin/2015/08/25/flugen-snags-9-4m-for-phase-i-trial-of-universal-flu-vaccine/

Aug 25, 2015 ... ... for its flagship vaccine candidate, designed to protect against multiple types of influenza, president and CEO Paul Radspinner said Monday.

11-6-14 speakers - WARF

www.warf.org/through-programs-and-events/for-inventors-entrepreneurs-and-researchers/entrepreneurons/november-6-speakers/11-6-14.cmsx

Nov 6, 2014 ... Paul Radspinner is a co-founder, president and CEO of FluGen Inc., a Madison influenza vaccines and vaccines delivery company. He holds ...

FluGen-Arecor Partnership Enhances Promise of Universal Flu ...

www.arecor.com/news-events/flugen-arecor-partnership-enhances-promise-univers/

Jul 29, 2013 ... FluGen's CEO, Paul Radspinner, explains, “Projects with outstanding companies like Arecor are a critical part of our strategic plan. We're in a ...

FluGen Inc. - BiotechProfiles

www.biotechprofiles.com/companyprofile/FluGen.aspx

The company was founded in 2007 by Dr. Yoshihiro Kawaoka, Dr. Gabriele Neumann and Paul V. Radspinner to address three specific areas: increasing ...

FluGen Closes $12 Million Series A Financing | Business Wire

www.businesswire.com/news/home/20150825005469/en/FluGen-Closes-12-Million-Series-Financing

Aug 25, 2015 ... "FluGen has made significant progress in the development of our REDEE FLU influenza vaccine candidate," said Paul V. Radspinner, Chief ...

FluGen's Universal Flu Vaccine REDEE FLU™ Showcased at World ...

www.businesswire.com/news/home/20130206005979/en/FluGen’s-Universal-Flu-Vaccine-REDEE-FLU™-Showcased

Feb 6, 2013 ... “At FluGen, our one and only focus is vaccine efficacy,” said Paul Radspinner, FluGen's president and CEO. “If REDEE FLU™ continues to ...

FluGen-Arecor Partnership successfully completes Innovate UK ...

www.arecor.com/news-events/flugen-arecor-partnership-successfully-completes/

Nov 6, 2014 ... Paul Radspinner, CEO of FluGen said “We are very pleased with the work Arecor has done with our lead vaccine candidate REDEE FLU™.

More Info

FluGen Inc. Focused on Efficacy – Our Staff

flugen.com

Paul Mr. Radspinner has over 15 years of experience in management roles overseeing international pharmaceutical operations, marketing and business ...

Questions for Biotechs:FluGen Inc.

www.tandfonline.com

Paul Radspinner; Email: pradspinner@flugen.com. Mr. Paul Radspinner is a Co- founder, President and Chief Executive Officer of FluGen Inc. How and when ...

FluGen Starts Clinical Trial for Universal Flu Vaccine | Xconomy

www.xconomy.com

Jul 27, 2016 ... They are broken into three groups of 32, and the dosage will increase with each group, said Paul Radspinner, FluGen's co-founder, president, ...